During the past decade, Centro Endocrinologic Tiempo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Endocrinologic Tiempo" are "Diabetes Mellitus, Type 2" (1 trials), "Diabetes Type 2" (1 trials) and "Diabetes, Type I" (1 trials). Many other conditions were trialed in "Centro Endocrinologic Tiempo" in a lesser frequency.

Most popular intervention types in "Centro Endocrinologic Tiempo" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Technosphere Insulin" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials), "Metformin & Secretagogues" (1 trials) and "Technosphere Insulin & Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Endocrinologic Tiempo" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro Endocrinologic Tiempo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Endocrinologic Tiempo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Endocrinologic Tiempo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".